The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
15008823
DOI
10.1111/j.1432-0436.2004.07201006.x
PII: S0301-4681(09)60283-8
Knihovny.cz E-zdroje
- MeSH
- adenokarcinom farmakoterapie patologie MeSH
- arachidonát-5-lipoxygenasa metabolismus MeSH
- buněčná diferenciace účinky léků MeSH
- buněčné dělení účinky léků MeSH
- buněčný cyklus účinky léků MeSH
- buňky HT-29 účinky léků MeSH
- butyráty farmakologie MeSH
- cyklooxygenasa 2 MeSH
- cyklooxygenasy metabolismus MeSH
- flavanony * MeSH
- flavonoidy farmakologie MeSH
- indomethacin farmakologie MeSH
- inhibitory cyklooxygenasy 2 MeSH
- inhibitory cyklooxygenasy farmakologie MeSH
- inhibitory lipoxygenas farmakologie MeSH
- izoenzymy antagonisté a inhibitory metabolismus MeSH
- kaspasa 3 MeSH
- kaspasy účinky léků metabolismus MeSH
- kyselina arachidonová metabolismus MeSH
- kyselina niflumová farmakologie MeSH
- kyselina nordihydroguaiaretová farmakologie MeSH
- lidé MeSH
- membránové proteiny MeSH
- nádory tračníku farmakoterapie metabolismus patologie MeSH
- synergismus léků MeSH
- TNF-alfa farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- arachidonát-5-lipoxygenasa MeSH
- baicalein MeSH Prohlížeč
- butyráty MeSH
- CASP3 protein, human MeSH Prohlížeč
- cyklooxygenasa 2 MeSH
- cyklooxygenasy MeSH
- flavanony * MeSH
- flavonoidy MeSH
- indomethacin MeSH
- inhibitory cyklooxygenasy 2 MeSH
- inhibitory cyklooxygenasy MeSH
- inhibitory lipoxygenas MeSH
- izoenzymy MeSH
- kaspasa 3 MeSH
- kaspasy MeSH
- kyselina arachidonová MeSH
- kyselina niflumová MeSH
- kyselina nordihydroguaiaretová MeSH
- membránové proteiny MeSH
- PTGS2 protein, human MeSH Prohlížeč
- TNF-alfa MeSH
The level of differentiation could influence sensitivity of colonic epithelial cells to various stimuli. In our study, the effects of TNF-alpha, inhibitors of arachidonic acid (AA) metabolism (baicalein, BA; indomethacin, INDO; niflumic acid, NA; nordihydroguaiaretic acid, NDGA), and/or their combinations on undifferentiated or sodium butyrate (NaBt)-differentiated human colon adenocarcinoma HT-29 cells were compared. NaBt-treated cells became growth arrested (blocked in G0/G1 phase of the cell cycle), and showed down-regulated Bcl-xL and up-regulated Bak proteins and increased expression of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX). These cells were more perceptive to anti-proliferative and apoptotic effects of TNF-alpha. Both inhibitors of LOX (BA and NDGA) and COX (INDO and NA) in higher concentrations modulated cell cycle changes accompanying NaBt-induced differentiation and induced various level of cell death in undifferentiated and differentiated cells. Most important is our finding that TNF-alpha action on proliferation and cell death can be potentiated by co-treatment of cells with AA metabolism inhibitors, and that these effects were more significant in undifferentiated cells. TNF-alpha and INDO co-treatment was associated with accumulation of cells in G0/G1 cell cycle phase, increased reactive oxygen species production, and elevated caspase-3 activity. These results indicate the role of differentiation status in the sensitivity of HT-29 cells to the anti-proliferative and proapoptotic effects of TNF-alpha, AA metabolism inhibitors, and their combinations, and imply promising possibility for novel anti-cancer strategies.
Citace poskytuje Crossref.org